Standard BioTools
LAB
LAB
99 hedge funds and large institutions have $223M invested in Standard BioTools in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
68% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 38
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $80K
Holders
99
Holding in Top 10
1
Calls
–
Puts
$80K
Top Buyers
| 1 | +$6.44M | |
| 2 | +$3.9M | |
| 3 | +$2.69M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.22M |
| 5 |
ICM
Indaba Capital Management
San Francisco,
California
|
+$2.09M |
Top Sellers
| 1 | -$9.77M | |
| 2 | -$7.75M | |
| 3 | -$3.79M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.27M |
| 5 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$2.21M |